M. Tamm (Basel, Switzerland), M. Vendrell Relat (Girona, Spain)
Health status impact of ciprofloxacin dry powder for inhalation in patients with non-cystic fibrosis bronchiectasis
B. Hampel, O. Schoeman, P. Reimnitz, P. Jones, R. Wilson (Berlin, Wuppertal, Germany; London, United Kingdom)
|  |
Pseudomonas aerugenosa sensitivity changes to antibiotics under the influence of dissolved ozone
A. Plotnikova, I. Belyanin, L. Selina, E. Shmelev (Moskow, Russian Federation)
| |
Influence of antibiotic resistance of pseudomonas aeruginosa on presenting features of community-acquired lower respiratory tract infections
P. Nikolova, Y. Ivanov, P. Pavlov, T. Popova, E. Borissova, P. Hristova (Pleven, Bulgaria)
|  |
Nebulized antibiotics in patients with non-cystic fibrosis bronchiectasis ans chronic pseudomonas aeruginosa infection
J. R. Donado-Uña, C. Jiménez-Navarro, M. E. Fuentes-Salazar, J. M. Ruiz-Giardin, M. A. Racionero-Casero, V. Valeri-Busto, E. Prats-Graciá, A. Zapatero-Gaviria (Fuenlabrada, Spain)
| |
Mannose binding lectin deficiency is associated with disease severity in patients with non-cystic fibrosis bronchiectasis
J. D. Chalmers, D. Kilpatrick, B. McHugh, P. Mandal, M. Smith, C. Doherty, J. Govan, A. T. Hill (Edinburgh, United Kingdom)
| |
Effects of subinhibitory concentrations of antibiotics on the biofilm formation of pseudomonas aeruginosa
H. Jiang, J. Li (Qingdao, China)
| |
Serum bactericidal activity in non cystic fibrosis bronchiectasis in patients with pseudomonas aeruginosa colonisation
D. Whitters, T. Wells, R. Stockley (Birmingham, United Kingdom)
| |
Sputum neutrophils are related to functional status in non-cystic fibrosis bronchiectasis in subjects in airway colonization
F. L. Dente, L. Malagrinò, F. Costa, L. Melosini, A. Di Franco, M. L. Bartoli, C. Ferretti, M. De Santis, E. Bacci, P. L. Paggiaro (Pisa, Italy)
| |
Survey of microbiology, pseudomonas eradication and antimicrobial prophylaxis in adult patients with non-cystic fibrosis bronchiectasis
R. Bhatnagar, N. Withers (Exeter, United Kingdom)
| |
Inhaled antibiotic treatment. Tolerance, compliance and quality of life
A. Alvarez, L. Ruano, M. Vendrell, R. Giron, M. P. Ausin, M. A. Martínez, M. Blanco, D. de la Rosa, D. Blanquer, I. Herrero, J. de Gracia (Barcelona, Girona, Madrid, Requena, A Coruna, Manacor, Zaragoza, Spain)
| |
Azithromycin, a novel maintenance therapy in patients with chronic non-CF suppurative lung disease
S. Twite, P. Stockton, S. Agarwal (Liverpool, United Kingdom)
| |
Airflow obstruction, functional disability and psychological dysfunction in bronchiectasis
G. Miller, H. Haja Mydin, A. De Soyza (Newcastle upon Tyne, United Kingdom)
| |
Staphylococcus aureus sensitivity changes to antibiotics under the influence of dissolved ozone
A. Plotnikova, I. Belyanin, L. Selina, E. Shmelev (Moskow, Moscow, Russian Federation)
| |
Identification of four different metallo-β-lactamases, IMP-1, IMP-7, IMP-19 and VIM-2, in Japanese general hospitals
N. Shibata, H. Ohbayashi (Mizunami, Japan)
| |
Anxiety and depression in patients with bronchiectais related to bacterial colonization
G. Fernandes, C. Martín-Carbajo, R. Girón, E. Vazquez, R. Gómez-Punter, C. Cisneros, L. Ramos, C. Rosado, J. Ancochea (Madrid, Zamora, Salamanca, Spain)
| |
Microbiological pattern in infective episodes of bronchiectasis
A. Khoury, H. Ismaeil, H. Hannan (Aleppo, Syrian Arab Republic)
| |
The role of viruses and other atypical bacteria in bronchiectasis‘ exacerbations
E. Balis, E. Metaxas, D. Chrysovergi, I. Papaparaskeuas, N. Spanakis, G. Tatsis, A. Tsakris (Athens, Greece)
| |